Novartis Corporation (NVS) Sits in the Penalty Box  
4/25/2012 8:07:17 AM

Earlier this year, I wrote a profile of Novartis and its chief executive, Joseph Jimenez, in which I detailed some of the issues hurting the company, which has traditionally been one of the stronger drug makers because of its great record of getting new medicines to market.